NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 2 Dec 2024
- Closes
- 13 Nov 2026, 23:59 UTC
- Value
- USD 3,50,000
- Reference
- PAR-25-271
- Location
- United States
- Sector
- Healthcare & Pharma
Details
This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated mid-phase clinical trials of natural products(i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. All applications submitted under this NOFO must be supported by sufficient preliminary data demonstrating bioavailability (if applicable) and documentation that the natural product produces a reproducible and measurable impact on target engagement (i.e., measure of the mechanism of action). Only in cases when it is not possible/practical to measure target engagement in the patient population of interest or when there is a fundamental understanding of the products mechanism of action will this preliminary data requirement be waived. Applications submitted to this NOFO should propose a mid-phase clinical trial to do the following: determine the optimal dose or formulation of a given natural product for use in a future multi-site efficacy trial; or determine which patient phenotypes will be responders versus non-responders to the natural product to inform inclusion/exclusion criteria of a future efficacy trial. Clinical trials submitted under this NOFO are expected to be hypothesis based, milestone-driven, and directly related to the research priorities and mission of NCCIH. This NOFO will not support single-site or multi-site efficacy or effectiveness trials, nor will it support trials to test natural products for the treatment or prevention of cancer. Applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact for the area of science for which they are planning to develop an application prior to submitting to this NO Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Estimated total programme funding: USD 350000
CFDA number(s): 93.213
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 204 notices from National Institutes of Health, going back to May 2023 — 186 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 225 open Healthcare & Pharma tenders in United States. This one closes in 66 days.
More from this buyer
- Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)· closes 13 Mar
- BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)· closes 5 Oct
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)· closes 8 May
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)· closes 8 Jan
- Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)· closes 8 Jan
Similar Healthcare & Pharma tenders
- Advancing bio-printing of living cells for regenerative medicine· closes 22 Sept
- New - VISN Specialty Testing Services· closes 6 Oct
- Survival Kit, Individua — 291 each, NSN· closes 15 Sept
- Anesthesia Units — Medical and Surgical Instruments, Equipment, and Supplies· closes 6 Oct
- Ballistic Shields — Armor, Personal· closes 10 Sept
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Office Renovation at Blk 27 Medical Drive at NUSMinistry of Defence 6 · Singapore
- New - VISN Specialty Testing ServicesVETERANS AFFAIRS, DEPARTMENT OF · VETERANS AFFAIRS, DEPARTMENT OF · 257-NETWORK CONTRACT OFFICE 17 (36C257) · United States
- Survival Kit, Individua — 291 each, NSNDEPT OF DEFENSE · DEFENSE LOGISTICS AGENCY · TROOP SUPPORT MEDICAL · DLA TROOP SUPPORT · United States
- Viscometer, Tube Type — 1 each, NSNDEPT OF DEFENSE · DEFENSE LOGISTICS AGENCY · TROOP SUPPORT MEDICAL · DLA TROOP SUPPORT · United States
- SomnoFlo Electronic Vaporizer Systems Brand Name or EqualVETERANS AFFAIRS, DEPARTMENT OF · VETERANS AFFAIRS, DEPARTMENT OF · 242-NETWORK CONTRACT OFFICE 02 (36C242) · United States
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →